Modified constraint-induced movement therapy or bimanual occupational therapy following injection of Botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: A randomised controlled trial methods paper

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Hoare, Brian J ^a,b   Imms, Christine ^a,c,d   Rawicki, Hyam B ^b   Carey, Leeanne ^a,e  

^a LA TROBE UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ARM; ARM MOVEMENT; ARTICLE; ASSISTING HAND ASSESSMENT; BIMANUAL OCCUPATIONAL THERAPY; CANADIAN OCCUPATIONAL PERFORMANCE MEASURE; CEREBRAL PALSY; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYING; DOUBLE BLIND PROCEDURE; FAMILY; FUNCTIONAL ASSESSMENT; GOAL ATTAINMENT; HAND FUNCTION; HEMIPLEGIA; HEMIPLEGIC CEREBRAL PALSY; HUMAN; INFANT; INTERMETHOD COMPARISON; LIMB MOVEMENT; MODIFIED ASHWORTH SCALE; MODIFIED CONSTRAINT INDUCED MOVEMENT THERAPY; MODIFIED TARDIEU SCALE; MOTIVATION; MOTOR ACTIVITY; MOTOR CONTROL; MOTOR PERFORMANCE; MOUTHING OBJECT; MOVEMENT THERAPY; MUSCLE STRETCHING; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PASSIVE MOVEMENT; PEDIATRIC EVALUATION OF DISABILITY INVENTORY; PEDIATRIC MOTOR ACTIVITY LOG; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUALITY OF UPPER EXTREMITY SKILLS TEST; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SAMPLE SIZE; SPASTICITY; SPLINTING; TASK PERFORMANCE; THROWING OBJECT; HAND; HEMISPHERIC DOMINANCE; MANIPULATIVE MEDICINE; MEDICAL RESEARCH; METHODOLOGY; MULTIMODALITY CANCER THERAPY; TIME; TREATMENT OUTCOME;

BIOMEDICAL RESEARCH; BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FUNCTIONAL LATERALITY; HAND; HEMIPLEGIA; HUMANS; INFANT; MOTOR SKILLS; MUSCULOSKELETAL MANIPULATIONS; NEUROMUSCULAR AGENTS; OCCUPATIONAL THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955118863     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-58     Document Type: Article

References (112)

1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Developmental Medicine and Child Neurology 2007, 109:8-14.
2. Smith LR, Ponten E, Hedstrom Y, Ward SR, Chambers H, Subramaniam S, Lieber RL. Novel transcriptional profile in wrist muscles from cerebral palsy patients. Biomedical Central Medical Genomics 2009, 2(1):44.
3. Lance J. Symposium synopsis 1980, Chicago: Year Book Medical Publishers.
4. Lieber RL, Friden J. Spasticity causes a fundamental rearrangement of muscle-joint interaction. Muscle & Nerve 2002, 25(2):265-270. 10.1002/mus.10036, 11870696.
5. Reid S, Lanigan A, Walstab J, Reddihough DS. Third report of the Victorian cerebral palsy register. 2005, Melbourne: Department of Child Development and Rehabilitation, Murdoch Children's Research Institute, Royal Children's Hospital.
6. Howard J, Soo B, Graham HK, Boyd RN, Reid S, Lanigan A, Wolfe R, Reddihough DS. Cerebral palsy in Victoria: motor types, topography and gross motor function. Journal of Paediatric Child Health 2005, 41:479-483.
7. Jessen C, Mackie P, Jarvis S. Epidemiology of cerebral palsy. Archives of Disease in Childhood Fetal and Neonatal Edition 1999, 80(2):158.
8. Eliasson AC, Krumlinde-Sundholm L, Shaw K, Wang C. Effects of constraint-induced movement therapy in young children with hemiplegic cerebral palsy: an adapted model. Developmental Medicine and Child Neurology 2005, 47(4):266-275. 10.1017/S0012162205000502, 15832550.
9. Hoare BJ, Russo R. Upper-limb movement training in children following injection of botulinum neurotoxin A. International Handbook of Occupational Therapy Interventions 2009, 343-350. New York: Springer Publishers, Soderback I.
10. Kuhtz-Buschbeck JP, Krumlinde-Sundholm L, Eliasson AC, Forssberg H. Quantitative assessment of mirror movements in children and adolescents with hemiplegic cerebral palsy. Developmental Medicine and Child Neurology 2000, 42:728-736. 10.1017/S0012162200001353, 11104343.
11. Vaz DV, Cotta Mancini M, Fonseca ST, Vieira DSR. Muscle stiffness and strength and their relation to hand function in children with hemiplegic cerebral palsy. Developmental Medicine and Child Neurology 2006, 48(9):728-733. 10.1017/S0012162206001563, 16904018.
12. Graham HK. Botulinum toxin-A in cerebral palsy: functional outcomes. Journal of Pediatrics 2000, 137(3):300-303. 10.1067/mpd.2000.109107, 10969251.
13. Graham HK, Selber P. Musculoskeletal aspects of cerebral palsy. The Journal of Bone and Joint Surgery: British Volume 2003, 2:157-166.
14. Hoare BJ, Imms C. Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for occupational therapists. American Journal of Occupational Therapy 2004, 58(4):389-397.
15. NIHCDCS Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement. November 12-14, 1990. Archives of Neurology 1991, 48(12):1294-1298. NIHCDCS.
16. de Paiva A, Meunier F, A, Molgo J, Aoki K, Dolly R. JO: Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:3200-3205. 10.1073/pnas.96.6.3200, 15919, 10077661.
17. BS Drugs: Botulinum Toxin. 2009, , http://www.medicareaustralia.gov.au/provider/pbs/drugs1/botulinum.jsp
18. WHO International Classification of Functioning, Disability and Health: ICF 2001, Geneva: World Health Organisation, WHO.
19. Hoare BJ, Wallen MA, Imms C, Villanueva E, Rawicki HB, Carey L. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy: An update. Cochrane Database of Systematic Reviews 2010, (1).
20. Fehlings D. International consensus based statements for the use of botulinum toxin in children and adults: executive summary. Developmental Medicince and Child Neurology 2009, 51(Suppl 2):39.
21. Sakzewski L, Ziviani J, Boyd RN. Systematic review and meta-analysis of therapeutic management of upper-limb dysfunction in children with congenital hemiplegia. Pediatrics 2009, 123(6):e1111-e1122. 10.1542/peds.2008-3335, 19451190.
22. Imms C. The evidence-base for upper extremity intervention for children with cerebral palsy. Improving hand function in children with cerebral palsy: Theory, evidence and intervention 2008, 396-417. London: Mac Keith Press, Eliasson AC, Burtner PA.
23. Lowe K, Novak I, Cusick A. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy. Developmental Medicine and Child Neurology 2006, 48(3):170-175. 10.1017/S0012162206000387, 16483391.
24. Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intra-muscular botulinum toxin type A and occupational therapy in the upper limbs of children with cerebral palsy: A randomised controlled trial. Archives of Physical Medicine and Rehabilitation 2007, 88:1-10. 10.1016/j.apmr.2006.10.017, 17207668.
25. Russo RN, Crotty M, Miller M, D, Murchland S, Flett P, Haan E. Upper limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: A single-blind randomised controlled trial. Pediatrics 2007, 119(5):1149-1158.
26. Speth LAWM, Leffers P, Janssen-Potten YJM, Vles JSH. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomised trial in children receiving intensive therapy. Developmental Medicine and Child Neurology 2005, 47:468-473. 10.1017/S0012162205000903, 15991867.
27. Kaplan MT, Bedell G. Motor skill acquisition frame of reference. Frames of Reference for Pediatric Occupational Therapy 1999, Baltimore: Williams & Wilkins, Kramer P, Honojosa J, 2.
28. Wallen M, Hoare BJ. Preliminary evidence suggests that hand-arm bimanual intensive therapy (HABIT) improves bimanual upper limb performance in children with mild to moderate hemiplegic cerebral palsy. Australian Occupational Therapy Journal 2009, 56(1):75-76.
29. Eliasson AC. Bimanual training for children with unilateral CP-is this something new?. Developmental Medicine and Child Neurology 2007, 49(11):806. 10.1111/j.1469-8749.2007.00806.x, 17979856.
30. Eliasson AC. Improving the use of hands in daily activities: aspects of the treatment of children with cerebral palsy. Physical and Occupational Therapy in Pediatrics 2005, 25(3):37-60.
31. Gordon AM, Schneider JA, Chinnan A, Charles JR. Efficacy of a hand-arm bimanual intensive therapy (HABIT) in children with hemiplegic cerebral palsy: a randomized control trial. Developmental Medicine and Child Neurology 2007, 49(11):830-838. 10.1111/j.1469-8749.2007.00830.x, 17979861.
32. Morris DM, Taub E. Constraint-induced therapy approach to restoring function after neurological injury. Topics in Stroke Rehabilitation 2001, 8(3):16-30. 10.1310/BLJX-M89N-PTPY-JDKW, 14523735.
33. Hoare BJ, Wasiak J, Imms C, Carey L. Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database of Systematic Reviews 2007, (2).
34. Boyd RN, Morris ME, Graham HK. Management of upper limb dysfunction in children with cerebral palsy: a systematic review. European Journal of Neurology 2001, 8(Suppl 5):150-166. 10.1046/j.1468-1331.2001.00048.x, 11851744.
35. DeLuca S. Intensive movement therapy with casting for children with hemiparetic cerebral palsy: A randomised controlled trial. Dissertation. 2002, University of Alabama at Birmingham.
36. Taub E, Uswatte G, Pidikiti R. Constraint-induced movement therapy: A new family of techniques with broad application to physical rehabilitation - A clinical review. Journal of Rehabilitation Research and Development 1999, 36(3):237-251.
37. Levy CE, Nichols DS, Schmalbrock PM, Keller P, Chakeres DW. Functional MRI evidence of cortical reorganization in upper-limb stroke hemiplegia treated with constraint-induced movement therapy. American Journal of Physical Medicine and Rehabilitation 2001, 80(1):4-12. 10.1097/00002060-200101000-00003, 11138954.
38. Liepert J. Motor cortex excitability in stroke before and after constraint-induced movement therapy. Cognitive and Behavioral Neurology 2006, 19(1):41-47. 10.1097/00146965-200603000-00005, 16633018.
39. Seitz RJ, Matyas TA, Carey LM. Neural plasticity as a basis for motor learning and neurorehabilitation. Brain Impairment 2008, 9(2):103-113.
40. Carr LJ, Harrison LM, Evans AL, Stephens JA. Patterns of central motor reorganization in hemiplegic cerebral palsy. Brain 1993, 116(5):1223-1247. 10.1093/brain/116.5.1223, 8221056.
41. Carr LJ. Development and reorganisation of descending motor pathways in children with hemiplegic cerebral palsy. Acta Pediatrica 1996, 85(Suppl 416):53-57.
42. Farmer SF, Harrison LM, Ingram DA, Stephens JA. Plasticity of central motor pathways in children with hemiplegic cerebral palsy. Neurology 1991, 41(9):1505.
43. Sutcliffe TL, Gaetz WC, Logan WJ, Cheyne DO, Fehlings DL. Cortical reorganization after modified constraint-induced movement therapy in pediatric hemiplegic cerebral palsy. Journal of Child Neurology 2007, 22(11):1281-1287. 10.1177/0883073807307084, 18006957.
44. Hoare BJ, Imms C, Carey L, Wasiak J. Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy: a Cochrane systematic review. Clinical Rehabilitation 2007, 21(8):675-685. 10.1177/0269215507080783, 17846067.
45. Sung IY, Ryu JS, Pyun SB, Yoo SD, Song WH, Park MJ. Efficacy of forced-use therapy in hemiplegic cerebral palsy. Archives of Physical Medicine and Rehabilitation 2005, 86(11):2195-2198. 10.1016/j.apmr.2005.05.007, 16271570.
46. Kuhnke N, Juenger H, Walther M, Berweck S, Mall V, Staudt M. Do subjects with congenital hemiparesis and ipsilateral cortico-spinal projections to the paretic hand respond differently to constraint-induced movement therapy?. Developmental Medicine and Child Neurology 2008, 50(12):898-903. 10.1111/j.1469-8749.2008.03119.x, 18811703.
47. Hoare BJ. Unravelling the cerebral palsy upper limb. Developmental Medicine and Child Neurology 2008, 50(12):887. 10.1111/j.1469-8749.2008.03130.x, 18811700.
48. Gordon AM, Chinnan A, Gill S, Petra E, Hung YC, Charles J. Both constraint-induced movement therapy and bimanual training lead to improved performance of upper extremity function in children with hemiplegia. Developmental Medicine and Child Neurology 2008, 50(12):957-958. 10.1111/j.1469-8749.2008.03166.x, 19160464.
49. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine 2008, 148(4):295-309.
50. Hoare BJ, Imms C, Carey L, Rawicki HB. A randomised controlled trial to evaluate the effect of modified constraint induced movement therapy or conventional occupational therapy following injection of botulinum toxin-A to improve bimanual performance in children with hemiplegic cerebral palsy. 2005, Australian and New Zealand Clinical Trials Registry.
51. Krumlinde-Sundholm L, Eliasson AC. Development of the Assisting Hand Assessment: a rasch-built measure intended for children with unilateral upper limb impairments. Scandinavian Journal of Occupational Therapy 2003, 10(1):16-26.
52. Krumlinde-Sundholm L, Holmefur M, Kottorp A, Eliasson AC. The Assisting Hand Assessment: current evidence of validity, reliability, and responsiveness to change. Developmental Medicine and Child Neurology 2007, 49(4):259-264. 10.1111/j.1469-8749.2007.00259.x, 17376135.
53. Holmefur M, Krumlinde-Sundholm L, Eliasson AC. Interrater and intrarater reliability of the Assisting Hand Assessment. American Journal of Occupational Therapy 2007, 61(1):79-84.
54. Holmefur M, Aarts P, Hoare BJ, Krumlinde-Sundholm L. Retest and Alternate forms reliability of the Assisting Hand Assessment. Journal of Rehabilitation Medicine 2009, 41:886-891. 10.2340/16501977-0448, 19841839.
55. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy 1987, 67(2):206-207.
56. Gregson J, Leathley M, Moore M, Sharma A, Smith T, Watkins C. Reliability of the tone assessment scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity. Archives of Physical Medicine and Rehabilitation 1999, 80(9):1013-1016. 10.1016/S0003-9993(99)90053-9, 10489001.
57. Patrick E, Ada L. The Tardieu Scale differentiates contracture from spasticity whereas the Ashworth Scale is confounded by it. Clinical Rehabilitation 2006, 20(2):173-182. 10.1191/0269215506cr922oa, 16541938.
58. Morris S. Ashworth and Tardieu Scales: Their clinical relevance for measuring spasticity in adult and paediatric neurological populations. Physical Therapy Reviews 2002, 7:53-62.
59. Fosang AL, Galea MP, McCoy AT, Reddihough DS, Story I. Measures of muscle and joint performance in the lower limb of children with cerebral palsy. Developmental Medicine and Child Neurology 2003, 45(10):664-670. 10.1017/S0012162203001245, 14515937.
60. Yam WK, Leung MS. Interrater reliability of modified Ashworth Scale and modified Tardieu Scale in children with spastic cerebral palsy. Journal of Child Neurology 2006, 21(12):1031-1035. 10.1177/7010.2006.00222, 17156693.
61. Olesch CA, Greaves SM, Imms C, Reid S, Graham HK. Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial. Developmental Medicine and Child Neurology 2009, 52(1):79-86. 10.1111/j.1469-8749.2009.03387.x, 19583742.
62. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticite. Rev Neurol 1954, 91:143-144.
63. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology 1999, 6(suppl 4):S23-S35.
64. Mackey AH, Walt SE, Lobb G, Stott SN. Intraobserver reliability of the modified Tardieu scale in the upper limb of children with hemiplegia. Developmental Medicine and Child Neurology 2004, 46(4):267-272. 10.1017/S0012162204000428, 15077704.
65. Scholtes VA, Becher JG, Beelen A, Lankhorst GJ. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Developmental Medicine and Child Neurology 2006, 48(1):64-73. 10.1017/S0012162206000132, 16359597.
66. DeMatteo C, Law M, Russell D, Pollock N, Rosenbaum P, Walter S. Quality of Upper Extremity Skills Test 1991, Hamilton: Neurodevelopmental Clinical Research Unit, Chedoke-McMaster Hospitals.
67. DeMatteo C, Law M, Russell DJ, Pollock N, Rosenbaum P, Walter S. The reliability and validity of the Quality of Upper Extremity Skills Test. Physical and Occupational Therapy in Pediatrics 1993, 13(2):1-18.
68. Law M, Cadman DT, Rosenbaum P, Walter S, Russell DJ. Neurodevelopmental therapy and upper-extremity inhibitive casting for children with cerebral palsy. Developmental Medicine and Child Neurology 1991, 33(5):379-387.
69. Fehlings D, Rang M, Glazier J, Steele C. An evaluation of Botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. Journal of Pediatrics 2000, 137(3):331-337. 10.1067/mpd.2000.108393, 10969256.
70. Haley SM, Coster WJ, Ludlow LH, Haltiwanger J, Andrellos P. Pediatric Evaluation of Disability Inventory: Development, Standardisation and Administration Manual. Volume 1.0 1992, Boston: PEDI Research Group.
71. Haley S, Coster W, Faas R. A content validity study of the Pediatric Evaluation of Disability Inventory. Pediatric Physical Therapy 1991, 3(4):177.
72. Boyd RN. The central and peripheral effects of botulinum toxin A in children with cerebral palsy. Doctor of Philosophy Thesis 2004, Victoria: Schools of Human BioSciences and Physiotherapy. Faculty of Health Sciences. La Trobe University.
73. Kawamura A, Campbell K, Lam-Damji S, Fehlings DL. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Developmental Medicine and Child Neurology 2007, 49(5):331-337. 10.1111/j.1469-8749.2007.00331.x, 17489805.
74. Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Physical Therapy 1990, 70(10):602-610.
75. Ziviani J, Ottenbacher KJ, Shephard K, Foreman S, Astbury W, Ireland P. Concurrent validity of the Functional Independence Measure for Children (WeeFIM) and the Pediatric Evaluation of Disabilities Inventory in children with developmental disabilities and acquired brain injuries. Physical and Occupational Therapy in Pediatrics 2001, 21(2-3):91-101. 10.1080/J006v21n02_08, 12029858.
76. Bourke-Taylor H. Melbourne Assessment of Unilateral Upper Limb Function: construct validity and correlation with the Pediatric Evaluation of Disability Inventory. Developmental Medicine and Child Neurology 2003, 45(2):92-96. 10.1017/S0012162203000185, 12578234.
77. Nichols DS, Case-Smith J. Reliability and validity of the Pediatric Evaluation of Disability Inventory. Pediatric Physical Therapy 1996, 8(1):15-24.
78. Berg M, Jahnsen R, Froslie KF, Hussain A. Reliability of the Pediatric Evaluation of Disability Inventory (PEDI). Physical & Occupational Therapy in Pediatrics 2004, 24(3):61-77. 10.1300/J006v24n03_05, 15257969.
79. Iyer LV, Haley S, M, Watkins MP, Dumas HM. Establishing minimal clinically important differences for scores on the Pediatric Evaluation of Disability Inventory for Inpatient Rehabilitation. Physical Therapy 2003, 83(10):888-898.
80. Wright FV, Boschen KA, Faas RM. The Pediatric Evaluation of Disability Inventory (PEDI): validation of a new functional assessment outcome instrument. Canadian Journal of Rehabilitation 1993, 7:41-42.
81. Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N. Canadian Occupational Performance Measure 1998, Ottawa: CAOT Publications.
82. Law M, Polatajko H, Pollock N, McColl MA, Carswell A, Baptiste S. Pilot testing of the Canadian Occupational Performance Measure: clinical and measurement issues. Canadian Journal of Occupational Therapy 1994, 61:191-197.
83. Toomey M, Nicholson D, Carswell A. The clinical utility of the Canadian Occupational Performance Measure. Canadian Journal of Occupational Therapy 1995, 62:242-249.
84. Chan CCH, Lee TMC. Validity of the Canadian Occupational Performance Measure. Occupational Therapy International 1997, 4(3):231-249.
85. Carswell A, McColl MA, Baptiste S, Law M, Polatajko HJ, Pollock N. The Canadian Occupational Performance Measure: a research and clinical literature review. Canadian Journal of Occupational Therapy 2004, 71(4):210-222.
86. Barry MJ, Albright L. Use of the Canadian Occupational Performance Measure as an outcome measure for intrathecal baclofen therapy. Paediatric Physical Therapy 1996, 8(1):183-184.
87. Stewart S, Neyerlin-Beale J. The impact of community paediatric occupational therapy on children with disability and their carers. British Journal of Occupational Therapy 2000, 63:373-379.
88. Miller LT, Polatajko HJ, Missiuna C, Mandich AD, Macnab JJ. A pilot of a cognitive treatment for children with developmental coordination disorder. Human Movement Science 2001, 20:183-210. 10.1016/S0167-9457(01)00034-3, 11471396.
89. Cusick A, McIntyre S, Novak I, Lannin N, Lowe K. A comparison of Goal Attainment Scaling and the Canadian Occupational Performance Measure for pediatric rehabilitation research. Pediatric Rehabilitation 2006, 9(2):149-157.
90. Kiresuk TJ, Smith JE, Cardillo JE. Goal Attainment Scaling: Applications, Theory and Measurement 1994, Hillsdale: Lawrence Erlbaum Associates.
91. Tennant A. Goal attainment scaling: Current methodological challenges. Disability & Rehabilitation 2007, 29(20-21):1583-1588.
92. Steenbeek D, Ketelaar M, Galama K, Gorter JW. Goal attainment scaling in paediatric rehabilitation: a critical review of the literature. Developmental Medicine and Child Neurology 2007, 49:550-556. 10.1111/j.1469-8749.2007.00550.x, 17593130.
93. McLaren C, Rodger S. Goal attainment scaling: Clinical implications for paediatric occupational therapy. Australian Occupational Therapy Journal 2003, 50(4):216-224.
94. Taub E, Ramey SL, DeLuca S, Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics 2004, 113(2):305-312. 10.1542/peds.113.2.305, 14754942.
95. Wallen M, Bundy A, Pont K, Ziviani J. Psychometric properties of the Pediatric Motor Activity Log used for children with cerebral palsy. Developmental Medicine and Child Neurology 2009, 51(3):200-208. 10.1111/j.1469-8749.2008.03157.x, 19018839.
96. Williams PE, Goldspink G. Connective tissue changes in immobilised muscle. Journal of Anatomy 1984, 138(Pt 2):343-350. 1164074, 6715254.
97. Williams PE, Catanese T, Lucey EG, Goldspink G. The importance of stretch and contractile activity in the prevention of connective tissue accumulation in muscle. Journal of Anatomy 1988, 158:109-114. 1261981, 3225214.
98. Light KE, Nuzik S, Personius W, Barstrom A. Low-load prolonged stretch vs. high-load brief stretch in treating knee contractures. Physical Therapy 1984, 64(3):330-333.
99. Steffen TM, Mollinger LA. Low-load, prolonged stretch in the treatment of knee flexion contractures in nursing home residents. Physical Therapy 1995, 75(10):886-895.
100. Pin T, Dyke P, Chan M. The effectiveness of passive stretching in children with cerebral palsy. Developmental Medicine and Child Neurology 2006, 48(10):855-862. 10.1017/S0012162206001836, 16978468.
101. Smith RA, Wrisberg CA. Motor learning and performance. A situation-based learning approach 2008, United States of America: Human Kinetics Publisher, 4.
102. Larin HM. Motor learning: a practical framework for paediatric physiotherapy. Physiotherapy Theory and Practice 1998, 14(1):33-47.
103. Meichenbaum D, Goodman J. Reflection impulsivity and verbal control of motor behavior. Child Development 1969, 40:785-797.
104. Meichenbaum D, Goodman J. Training impulsive children to talk to themselves: A means of developing self-control. Journal of Abnormal Psychology 1971, 77:115-126. 10.1037/h0030773, 5550424.
105. Steenbergen B, Verrel J, Gordon AM. Motor planning in congenital hemiplegia. Disability & Rehabilitation 2007, 29(1):13-23.
106. Steenbergen B, Gordon AM. Activity limitation in hemiplegic cerebral palsy: evidence for disorders in motor planning. Developmental Medicine and Child Neurology 2006, 48(9):780-783. 10.1017/S0012162206001666, 16904028.
107. Hoare BJ, Krumlinde-Sundholm L, Randall L. Using the Assisting Hand Assessment for treatment planning: Advanced practitioners workshop. Third International Cerebral Palsy Conference 2009, Sydney, Australia.
108. Polatajko HJ, Macnab JJ, Anstett B, Malloy-Miller T, Murphy K, Noh S. A clinical trial of the process-oriented treatment approach for children with developmental co-ordination disorder. Developmental Medicine and Child Neurology 1995, 37(4):310-319.
109. Missiuna C, Mandich Polatajko H. Malloy-Miller: Cognitive orientation to daily occupational performance (CO-OP): Part 1. Physical and Occupational Therapy in Pediatrics 2001, 20(2/3):69-81.
110. Douglas VI, Parry P, Marton P, Garson C. Assessment of a cognitive training program for hyperactive children. Journal of Abnormal Child Psychology 1976, 4(4):389-410. 10.1007/BF00922535, 1002950.
111. Meichenbaum D. Cognitive-behavior modification: An integrative approach 1977, New York: Plenum Press.
112. Sterne JA, Davey Smith G. Sifting the evidence-what's wrong with significance tests?. British Medical Journal 2001, 322(7280):226-231. 10.1136/bmj.322.7280.226, 1119478, 11159626.